Prestige Consumer Healthcare (PBH) EBT (2010 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly EBT came in at $61.8 million in Q4 2025, down 22.88% year-on-year from $80.2 million in Q4 2024, and down 10.59% quarter-over-quarter from $69.1 million in Q3 2025.
Prestige Consumer Healthcare (PBH) EBT (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's EBT history runs 16 years deep, the most recent figure standing at $61.8 million for Q4 2025.
- On a quarterly basis, EBT fell 22.88% year-over-year to $61.8 million in Q4 2025; TTM through Dec 2025 was $266.7 million, a 3.92% decrease from a year earlier, with the FY2025 full-year figure at $284.2 million, up 2.96% from the prior year.
- EBT retreated to $61.8 million in Q4 2025 per PBH's latest filing, from $69.1 million in the prior quarter.
- Across five years, EBT topped out at $80.2 million in Q4 2024 and bottomed at -$299.5 million in Q1 2023.
- The 5-year median for EBT is $67.7 million (2022), against an average of $48.1 million.
- Across the five-year window, EBT plunged 591.3% in 2023 and soared 122.48% in 2024, its largest moves.
- Year by year, EBT stood at $65.5 million in 2021, then advanced by 4.01% to $68.1 million in 2022, then climbed by 2.14% to $69.6 million in 2023, then rose by 15.21% to $80.2 million in 2024, then dropped by 22.88% to $61.8 million in 2025.
- Per Business Quant, the three latest PBH EBT figures stand at $61.8 million (Q4 2025), $69.1 million (Q3 2025), and $61.8 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 437.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 758.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.90 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 318.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -247.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 246.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 87.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | 61.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 61.81 Mn |
| Sep 30, 2025 | 69.13 Mn |
| Jun 30, 2025 | 61.78 Mn |
| Mar 31, 2025 | 73.96 Mn |
| Dec 31, 2024 | 80.15 Mn |
| Sep 30, 2024 | 71.66 Mn |
| Jun 30, 2024 | 58.41 Mn |
| Mar 31, 2024 | 67.32 Mn |
| Dec 31, 2023 | 69.58 Mn |
| Sep 30, 2023 | 70.42 Mn |
| Jun 30, 2023 | 68.71 Mn |
| Mar 31, 2023 | -299.52 Mn |
| Dec 31, 2022 | 68.12 Mn |
| Sep 30, 2022 | 66.59 Mn |
| Jun 30, 2022 | 70.90 Mn |
| Mar 31, 2022 | 60.97 Mn |
| Dec 31, 2021 | 65.49 Mn |
| Sep 30, 2021 | 59.63 Mn |
| Jun 30, 2021 | 76.37 Mn |
| Mar 31, 2021 | 40.37 Mn |